RADiCAIT

About RADiCAIT

RADiCAIT develops artificial intelligence technology that converts standard CT scans into PET‑level functional images, providing clinicians with detailed physiological insights without the need for radioactive tracers or additional hardware. Their Insilico PET® solution targets the imaging bottleneck in cardiology, neurology and oncology, enabling faster, safer and scalable disease detection, staging and treatment planning. The company operates in the healthcare AI sector, collaborating with leading academic and clinical institutions and is based in the United Kingdom.